Vitamin K Administration

Introduction to Vitamin K Administration

Vitamin K administration is recommended for patients with vitamin K deficiency or those taking warfarin with elevated INR levels, as suggested by the American College of Chest Physicians and the American College of Cardiology 1, 2

The American College of Critical Care recommends 10 mg IV vitamin K1 (phytonadione) daily for acute correction 3
Intravenous vitamin K may temporarily correct INR in cholestatic liver disease, with a strength of evidence level of moderate 4
Rare anaphylactoid reactions with bronchospasm and cardiac arrest have been reported after IV vitamin K1 administration, highlighting the need for careful monitoring and dosage adjustment in patients receiving vitamin K therapy, as noted in Critical Care 3, 5

For less urgent situations, 5-10 mg oral vitamin K1 daily is recommended, according to the Critical Care guideline 3
Low-dose oral vitamin K (1-2.5mg) can reduce INR from 5.0-9.0 to 2.0-5.0 within 24-48 hours, and for INR >10.0, a higher dose of 5mg may be appropriate, as noted by the American College of Cardiology and the American College of Chest Physicians 1
Patients on warfarin should maintain consistent vitamin K intake rather than restricting it, as fluctuations in dietary vitamin K can affect warfarin stability, recommends the American College of Cardiology 2

Patients with INR >10 without bleeding, those with vitamin K deficiency due to malnutrition, cholestasis, or prolonged antibiotic therapy, and those with unexplained variability in warfarin response may benefit from vitamin K supplementation, as recommended by the American College of Chest Physicians 1
Patients taking warfarin with INRs between 4.5 and 10 without bleeding do not require routine vitamin K supplementation, as evidence shows no benefit for patient-important outcomes like reduced bleeding, according to the American College of Cardiology 1
Coagulopathy in decompensated liver disease results from multiple factors, including decreased synthesis of both pro- and anticoagulant factors, thrombocytopenia, altered fibrinolysis, and potential hyperfibrinolysis in advanced disease, with a strength of evidence level of high 4

Patients on warfarin should have their INR closely monitored after vitamin K administration to ensure appropriate correction, with careful consideration of risks and benefits, particularly in patients on warfarin therapy 1
Excessive vitamin K can lead to warfarin resistance for days to weeks, and the risk of thromboembolism from overcorrection is similar to the risk of bleeding from over-anticoagulation, highlighting the need for judicious use of vitamin K supplementation 1
No evidence supports prophylactic fresh frozen plasma (FFP) or platelet transfusions to prevent spontaneous bleeding, with a strength of evidence level of high 4
Traditional coagulation tests (INR, APTT) do not predict post-procedural bleeding in cirrhosis, with a strength of evidence level of high 4

Vitamin K administration has limited value in managing coagulopathy due to decompensated liver disease and should not be routinely used unless there is evidence of vitamin K deficiency from cholestasis, malnutrition, or prolonged antibiotic therapy, as recommended by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver 4, 6
Viscoelastic testing may better guide transfusion needs than INR/platelet count, with a strength of evidence level of moderate 7
For high-risk procedures, consider maintaining hematocrit ≥25%, platelets >50 × 10^9/L, and fibrinogen >120 mg/dL, with a strength of evidence level of moderate 6, 7
Prothrombin complex concentrates may be considered for urgent procedures but carry thrombotic risk, with a strength of evidence level of moderate 4, 6

Measurement of PIVKA-II (protein induced by vitamin K absence or antagonism-II) is a sensitive biomarker of hepatic subclinical vitamin K deficiency, and prothrombin time and other coagulation tests can also be used to diagnose vitamin K deficiency 5
Vitamin K administration, either orally or parenterally, is the primary treatment for vitamin K deficiency, with IV administration having a maximum effect in 6-12 hours and oral supplementation taking about 24 hours for full effect, and for severe bleeding, prothrombin complex concentrate may be used alongside vitamin K 5, 8
Adequate dietary intake of vitamin K, found in leafy greens and cruciferous vegetables, can help prevent deficiency, and monitoring patients on antibiotics or with malabsorption conditions can also help prevent vitamin K deficiency 5